@article{bbbb64f46bef42f2b49e7bc26b1d201f,
title = "Efficacy and Acceptability of Remote Cognitive Behavioral Therapy for Patients With Major Depressive Disorder in Japanese Clinical Settings: A Case Series",
abstract = "Remote cognitive and behavioral therapy (CBT) via videoconference has been garnering attention as a means of improving access to CBT for depression, in particular during the coronavirus disease 2019 pandemic. However, there is a lack of evidence supporting its implementation in Japanese clinical settings. This case series aimed to establish preliminary evidence of whether remote CBT can be an effective therapy for major depression in Japanese clinical settings. Five patients who met the diagnostic criteria for major depressive disorder were enrolled and underwent remote CBT via videoconference and face-to-face assessment interviews. The results showed that remote CBT via videoconference improved depressive symptoms, enabling a relatively high level of patient satisfaction and working alliance. Moreover, detailed feedback from our patients showed that continuous monitoring was preferable for increasing treatment engagement. Further research is warranted to test the efficacy and acceptability of remote CBT via videoconference for treating major depression.",
keywords = "cognitive behavioral therapy, depression, teletherapy, videoconference",
author = "Waka Nogami and Atsuo Nakagawa and Noriko Kato and Yohei Sasaki and Taishiro Kishimoto and Masaru Horikoshi and Masaru Mimura",
note = "Funding Information: Dr. Nakagawa has received royalties from Igaku-Shoin and Kongo-Shuppan publishers for CBT textbooks. Dr. Kishimoto has received research grant from MICIN. Dr. Horikoshi has received royalties from Igaku-Shoin publisher for CBT textbooks. All the other authors declare that they have no conflicts of interest. Funding Information: This study was funded by Pfizer Health Research Foundation, the Inogashira Hospital Grants for Psychiatry Research, the Intramural Research Grant (grant No. 30-2) for Neurological and Psychiatric Disorders, Japan Agency for Medical Research and Development (AMED grant No. 16lk1010023h0001), and the MGH-SAFER grant. The funders had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, and decision to submit the manuscript for publication. Publisher Copyright: {\textcopyright} 2022",
year = "2022",
doi = "10.1016/j.cbpra.2022.04.002",
language = "English",
journal = "Cognitive and Behavioral Practice",
issn = "1077-7229",
publisher = "Elsevier Inc.",
}